CCTG MA.39 – Regional Radiotherapy in Biomarker Low-Risk Node Positive and T3N0 Breast Cancer (TAILOR RT)

NCT#:NCT03488693
NCT QR Code
Title:Regional Radiotherapy in Biomarker Low-Risk Node Positive and T3N0 Breast Cancer (TAILOR RT)
Protocol:CCTG MA.39
Cancer Type:Breast
Study Sponsor:Canadian Cancer Trials Group
NCI CIRB
Brief Summary:The purpose of this study is to compare the effects on low risk breast cancer receiving usual care that includes regional radiation therapy, with receiving no regional radiation therapy. Researchers want to see if not giving this type of radiation treatment works as well at preventing breast cancer from coming back.
Study Type:Interventional  
Date Opened at SVH:May 6, 2022
Recruitment Status:Recruiting
Study Population:
Eligibility Criteria:See SCHEMA
Principal Investigator:Jacob Andrade MD PhD, Coastal Radiation Oncology Salinas, (831) 758-2724
Participating Institution:Salinas Valley Health
SVH Clinical Research Program:Terri Nielsen, MSJ, RN, CCRP, Clinical Research Program Manager, [email protected]
Link to ClinicaTrials.govhttps://clinicaltrials.gov/ct2/show/record/NCT03488693?term=CCTG+MA.3&draw=2&rank=1
SchemaSchema